CAMP4 Therapeutics Competitors and Similar CompaniesClear all
CAMP4 Therapeutics's competitors and similar companies include Skyhawk Therapeutics, Oxford BioTherapeutics, Adverum Biotechnologies and Generation Bio.
 CAMP4 Therapeutics CAMP4 Therapeutics is a biotechnology company that develops antisense oligonucleotide therapeutics targeting gene expression. |  Skyhawk Therapeutics Skyhawk Therapeutics is a drug discovery and development company focused on revolutionizing disease treatment with small molecules that correct RNA expression. |  Oxford BioTherapeutics Oxford BioTherapeutics develops medicines for cancer and companion diagnostics for selected antibody programs. |  Adverum Biotechnologies Adverum Biotechnologies (formerly known as Avalanche Biotechnologies) is a clinical-stage gene therapy company targeting unmet medical need in ophthalmology and rare diseases. | ||
Founding Date | Founding Date 2016 | Founding Date 2016 | Founding Date 2004 | Founding Date 2006 | Founding Date 2016 |
Type | Type Public | Type Private | Type Private | Type Public | Type Public |
Tags | |||||
Locations | Locations Cambridge, US HQ | Locations Waltham, US HQ Basel, CH | Locations Milton, GB HQ San Jose, US | Locations Redwood City, US HQ Philadelphia, US | Locations Cambridge, US HQ |
Employees | Employees 66 | Employees 673% decrease | Employees 504% increase | Employees 11419% increase | Employees 85 |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 161.4 m | Valuation ($) 159.5 m |
Financial | |||||
Revenue (est.) | Revenue (est.) $3.5m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) £2.1m (FY, 2018) | Revenue (est.) $1m (FY, 2024) | Revenue (est.) $19.9m (FY, 2024) |
Net income | Net income ($80.4m) (FY, 2025) | Net income N/A | Net income (£6.5m) (FY, 2018) | Net income ($130.9m) (FY, 2024) | Net income ($131.7m) (FY, 2024) |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round $ 40m (almost 8 years ago) | Latest funding round $ 10m (almost 11 years ago) | Latest funding round N/A | Latest funding round N/A |
Total funding raised | Total funding raised $ 30m | Total funding raised $ 48m | Total funding raised $ 21.6m | Total funding raised $ 70.7m | Total funding raised $ 235m |
For sources of this data, please see the company profile
View Company Profiles
Skyhawk Therapeutics
HQ
Waltham, US
Employees
67↓ 3% decrease
Skyhawk Therapeutics is a drug discovery and development company focused on revolutionizing disease treatment with small molecules that correct RNA expression.
View companyOxford BioTherapeutics
HQ
Milton, GB
Employees
50↑ 4% increase
Oxford BioTherapeutics develops medicines for cancer and companion diagnostics for selected antibody programs.
View companyAdverum Biotechnologies
HQ
Redwood City, US
Employees
114↑ 19% increase
Adverum Biotechnologies (formerly known as Avalanche Biotechnologies) is a clinical-stage gene therapy company targeting unmet medical need in ophthalmology and rare diseases.
View company
Generation Bio
HQ
Cambridge, US
Employees
85
Generation Bio is a genetic medicines company creating gene therapy.
View company